Dr. Heather Wakelee: My App...
Dr. Geoffrey Oxnard on Tran...
Highlights in Lung Cancer, ...
Dr. Sarah Goldberg on the U...
Dr. Greg Riely on "I j...
Dr. Sarah Goldberg: What Me...
Dr. Geoffrey Oxnard: Are Pa...
Dr. Sarah Goldberg on "...
Dr. Geoffrey Oxnard: For Wh...
Dr. Rosalyn Juergens on &qu...
Dr. David Spigel: My Approa...
Dr. Greg Riely: My Approach...
Highlights in Lung Cancer, ...
Dr. Rosalyn Juergens on the...
Dr. Rosalyn Juergens on Man...
What Molecular Markers Do Y...
Dr. Heather Wakelee on &quo...
Dr. Ravi Salgia on "Wh...
Dr. Rosalyn Juergens: Recom...
Dr. David Spigel on the Uti...
Dr. Karen Kelly: My Approac...
Dr. Ravi Salgia: For Which ...
ASCO Lung Cancer Highlights...
Dr. Phil Bonomi: For Which ...
Dr. Greg Riely on "Whi...
Dr. Rosalyn Juergens: How D...
Living with Lung Cancer
Can or Will Specific Molecu...
Are There Clinically Signif...
New Ideas and New Treatment...
ROS-1 Rearrangements: What ...
Crizotinib for First Line T...
Timing of Second Generation...
Ceritinib and Other Second ...
ALK Rearrangements: What Ar...
TWiV #161 - Concerto in B